Form 8-K · Current report
The Coca-Cola Company 8-K, filed Oct 27, 2026
- Filed
- CIK
- 0000021344
- Accession no.
- 0001628280-26-067403
Summary
The Coca-Cola Company reported third-quarter 2026 results with net revenues up 7% to $13.4 billion, unit case volume up 5%, operating income up 12% and EPS up 8% to $0.93, and raised its full-year guidance. CEO Henrique Braun said the results reflected sustained momentum across the company's global system and confidence in the updated guidance.
Key points
- Organic revenues (non-GAAP) grew 7% and comparable currency neutral operating income (non-GAAP) grew 8%.
- Operating margin was 33.4% versus 32.0% a year earlier; comparable operating margin (non-GAAP) was 32.9% versus 31.9%.
- Comparable EPS (non-GAAP) grew 11% to $0.91, including a 2-point currency tailwind.
- Unit case volume growth was led by India, China, Mexico and Brazil, with Coca-Cola Zero Sugar up 16%; the company gained value share in total nonalcoholic ready-to-drink beverages.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02. Results of Operations and Financial Condition. Attached as Exhibit 99.1 is a copy of a press release of The Coca-Cola Company (“company”), dated October 27, 2026, reporting the company’s financial results for the third quarter 2026. The information in this Item 2.02, including the Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing. Item 9.01(d). Financial Statements and Exhibits. EXHIBIT INDEX Exhibit No. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.